Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

    Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai in Breast Cancer (2024)

  2. No Access

    Article

    Circulating Exosomal MicroRNA Signature Predicts Peritoneal Metastasis in Patients with Advanced Gastric Cancer

    Despite a radical operation, about half of gastric cancer (GC) patients with advanced GC experience peritoneal metastasis (PM), and the patients with PM have a poor prognosis. However, because staging laparosc...

    Yuma Wada MD, PhD, Masaaki Nishi MD, PhD in Annals of Surgical Oncology (2024)

  3. Article

    Open Access

    Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study

    In the global phase 3 DESTINY-Breast04 study (NCT03734029), the anti-human epidermal growth factor 2 (HER2) antibody–drug conjugate trastuzumab deruxtecan (T-DXd) demonstrated a statistically significant impro...

    Toshinari Yamashita, Joo Hyuk Sohn, Eriko Tokunaga, Naoki Niikura in Breast Cancer (2024)

  4. Article

    Open Access

    The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

    The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition was published in June 2022. The guidelines were prepared while conforming as much as possible to the “Minds Manua...

    Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai in Breast Cancer (2024)

  5. No Access

    Article

    ASO Visual Abstract: A Prospective, Multicenter, Phase II, Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement

    Naoki Ikenaga MD, PhD, Yoshihiro Miyasaka MD, PhD in Annals of Surgical Oncology (2023)

  6. Article

    Open Access

    A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy

    Breast-conserving surgery with radiotherapy is one of standard treatments for early breast cancer. However, it is regarded as an option to treat elderly patients with small hormone receptor-positive breast can...

    Shozo Ohsumi, Reiki Nishimura, Norikazu Masuda, Sadako Akashi-Tanaka in Breast Cancer (2023)

  7. No Access

    Article

    A Prospective Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement

    Only two clinical trials have shown the effects of neoadjuvant treatment for borderline resectable pancreatic cancer with arterial involvement (BRPC-A). Here, we aimed to analyze the efficacy and safety of neo...

    Naoki Ikenaga MD, PhD, Yoshihiro Miyasaka MD, PhD in Annals of Surgical Oncology (2023)

  8. Article

    ASO Visual Abstract: Propensity Score-Matched Analysis of the Short- and Long-Term Outcomes of Robotic Versus Laparoscopic Gastrectomy for Gastric Cancer

    Masaaki Nishi MD, PhD, FACS, Mistuo Shimada MD in Annals of Surgical Oncology (2022)

  9. No Access

    Article

    Propensity Score-Matched Analysis of the Short- and Long-Term Outcomes of Robotic Versus Laparoscopic Gastrectomy for Gastric Cancer

    Robotic gastrectomy (RG) has been rapidly adopted for gastric cancer (GC) treatment. However, the benefits of RG over laparoscopic gastrectomy (LG) for GC remain unclear.

    Masaaki Nishi MD, PhD, FACS, Mistuo Shimada MD in Annals of Surgical Oncology (2022)

  10. Article

    Open Access

    Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy

    Several studies have recently reported that the relationships between serum vitamin D and the prognosis or the pathological response to neoadjuvant chemotherapy (NAC) in breast cancer. However, there are no da...

    Eriko Tokunaga, Takanobu Masuda, Hideki Ijichi, Wakako Tajiri in Breast Cancer (2022)

  11. Article

    Open Access

    Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

    This was a Japanese subpopulation analysis of MONARCH 3, a randomized, double-blind, placebo-controlled phase 3 study of abemaciclib plus nonsteroidal aromatase inhibitors (NSAIs) for initial therapy for advan...

    Masato Takahashi, Eriko Tokunaga, Joji Mori, Yoshinori Tanizawa in Breast Cancer (2022)

  12. Article

    Open Access

    Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study

    We conducted a prospective study with the intention to omit surgery for patients with ductal carcinoma in situ (DCIS) of the breast. We aimed to identify clinicopathological predictors of postoperative upstagi...

    Kiyo Tanaka, Norikazu Masuda, Naoki Hayashi, Yasuaki Sagara, Fumikata Hara in Breast Cancer (2021)

  13. Article

    Open Access

    The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer

    Clinical Treatment Score post-5 years (CTS5) is a promising prognostic tool to evaluate late distant recurrence (DR) risk for breast cancer after 5-year adjuvant endocrine therapy.

    Wakako Tajiri, Hideki Ijichi, Katsumi Takizawa, Yumiko Koi in Breast Cancer (2021)

  14. No Access

    Article

    Total Lesion Glycolysis Ratio in Positron Emission Tomography/Computed Tomography Images During Neoadjuvant Chemotherapy Can Predict Pathological Tumor Regression Grade and Prognosis in Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus

    The usefulness of quantitating tumor lesion glycolysis (TLG) from 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) findings as a tool for determining the effect of neoadjuvant ...

    Akari Sonoda MD, Naoya Yoshida MD, PhD in Annals of Surgical Oncology (2021)

  15. Article

    Open Access

    The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution

    The TNM system, which reflects the anatomical extent of disease, was used for stage definition. In the recently published AJCC 8th edition, the new staging system of the clinical and pathological prognostic st...

    Eriko Tokunaga, Hideki Ijichi, Wakako Tajiri, Takanobu Masuda in Breast Cancer (2020)

  16. No Access

    Article

    Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases

    Liver fibrosis influences liver regeneration and surgical outcomes, and several noninvasive models based on laboratory data have been developed to predict liver fibrosis. This study was performed to determine ...

    Takahiko Akiyama MD, Yuji Miyamoto MD, PhD in Annals of Surgical Oncology (2020)

  17. No Access

    Article

    Wives as Key Persons Positively Impacting Prognosis for Male Patients Undergoing Esophagectomy for Esophageal Cancer: A Retrospective Study from a Single Japanese Institute

    Identification of a key person for supporting patients with activities of daily living after esophagectomy can contribute to patients’ nutrition, rehabilitation, mental status, and determination of treatments ...

    Naoya Yoshida MD, PhD, Yuki Adachi MD, Takeshi Morinaga MD in Annals of Surgical Oncology (2020)

  18. Article

    Open Access

    Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study

    Assessing survival risk is important for discussing treatment options with estrogen receptor-positive (ER+) advanced breast cancer (ABC) patients. However, there are few reports from large-scale databases on t...

    Hidetoshi Kawaguchi, Norikazu Masuda, Takahiro Nakayama, Kenjiro Aogi in Breast Cancer (2020)

  19. No Access

    Article

    Feasibility and Safety of Early Oral Intake and Discharge After Total or Proximal Gastrectomy: An Analysis of Consecutive Cases Without Exclusion Criteria

    Postoperative feeding is administered relatively early in gastric surgery, especially distal gastrectomy, but its feasibility and safety for proximal gastric surgery remains unclear.

    Masatoshi Nakagawa MD, PhD, Masanori Tokunaga MD, PhD in Annals of Surgical Oncology (2020)

  20. Article

    Open Access

    Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study

    To explore the actual status of chemotherapy-induced nausea and vomiting (CINV) through a multicenter prospective cohort study.

    Yoichi Naito, Yuichiro Kai, Takashi Ishikawa, Tomoyuki Fujita in Breast Cancer (2020)

previous disabled Page of 4